Harnessing the synergy of seasoned experts and sophisticated AI, we're revolutionizing the drug discovery and development process across biology, chemistry, and clinical stages, paving the way for groundbreaking therapeutic advancements. AlphaMeld Corporation is a wholly owned subsidiary of InveniAI LLC.